Literature DB >> 5923022

A critical evaluation of nalidixic acid in urinary-tract infections.

A R Ronald, M Turck, R G Petersdorf.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 5923022     DOI: 10.1056/NEJM196611172752001

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  49 in total

Review 1.  The quinolones and renal infection.

Authors:  A Ronald
Journal:  Drugs       Date:  1999       Impact factor: 9.546

2.  In vitro evaluation of a new quinolone antibacterial.

Authors:  G Stilwell; K Holmes; M Turck
Journal:  Antimicrob Agents Chemother       Date:  1975-04       Impact factor: 5.191

3.  In vitro activity of cinoxacin, an organic acid antibacterial.

Authors:  S Kurtz; M Turck
Journal:  Antimicrob Agents Chemother       Date:  1975-03       Impact factor: 5.191

4.  Changes in the sensitivity of urinary pathogens to quinolones between 1987 and 1990 in France.

Authors:  G Aubert; P P Levy; A Ros; R Meley; B Meley; A Bourge; G Dorche
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-05       Impact factor: 3.267

5.  First clinical isolate of highly fluoroquinolone-resistant Escherichia coli in Scandanavia.

Authors:  M Jonsson; M Walder; A Forsgren
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-11       Impact factor: 3.267

6.  Cross-resistance and cross-susceptibility between fluoroquinolone agents.

Authors:  A L Barry; P C Fuchs
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-12       Impact factor: 3.267

7.  An outbreak of infantile gastroenteritis due to E. coli 0142.

Authors:  D H Kennedy; G H Walker; R J Fallon; J F Boyd; R J Gross; B Rowe
Journal:  J Clin Pathol       Date:  1973-10       Impact factor: 3.411

8.  Reduced fluoroquinolone susceptibility in Salmonella enterica serotypes in travelers returning from Southeast Asia.

Authors:  A Hakanen; P Kotilainen; P Huovinen; H Helenius; A Siitonen
Journal:  Emerg Infect Dis       Date:  2001 Nov-Dec       Impact factor: 6.883

9.  Comparative efficacy and safety of nalidixic acid versus trimethoprim/sulfamethoxazole in treatment of acute urinary tract infections in college-age women.

Authors:  A Iravani; G A Richard; H Baer; R Fennell
Journal:  Antimicrob Agents Chemother       Date:  1981-04       Impact factor: 5.191

10.  Selective gut decontamination with nalidixic acid or trimethoprim-sulfamethoxazole for infection prophylaxis in neutropenic cancer patients: relationship of efficacy to antimicrobial spectrum and timing of administration.

Authors:  E J Bow; E Rayner; B A Scott; T J Louie
Journal:  Antimicrob Agents Chemother       Date:  1987-04       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.